You are here: Industry Insights > Shares

News List

Shares in Mirati plummet after disappointing Phase II trial pharmafile
October 25, 2018
Shares in the California-based biotech Mirati Therapuetics plummeted on Monday after the company released disappointing results from their Phase II study of the experimental drug sitravatinib...
Brexit woe sends investors at animal medications business Dechra Pharmaceuticals out of the door with shares down by 21.4% newsnow
September 04, 2018
Brexit pessimism at animal medications business Dechra Pharmaceuticals caused investors to take flight yesterday.
Is Celgene Considering Going Private? biospace
March 16, 2018
Despite a deep pipeline and a market cap of $69.4 billion, Celgene shares are down 12 percent year to date.
Can 2018 Possibly Rival 2017's Biotechs Record Venture Capital Splurge? biospace
January 11, 2018
It was a banner year for the stock market, with the S&P 500 gaining 19.4%, while the iShares Nasdaq Biotechnology Index ETF (IBB) clocked in with an even more impressive 20.9% gain.
US$25 million share repurchase programme announced by PDL BioPharma pharmaasia
September 30, 2017
The new repurchase programme aims to acquire USD 25mn of PDL Biopharma common stock, with several transaction routes available.
Shanghai Fosun Pharmaceutical Group, Shandong Buchang Pharmaceutical, 4SC pharmaceutical-technology
May 27, 2017
Shanghai Fosun Pharmaceutical Group intends to raise approximately HK$2.32bn ($298.3m) through a private placement of 80.6 million shares.
Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ) en-cphi.cn
April 01, 2017
NeuroVive Pharmaceutical AB announced an increase of the number of shares and votes in NeuroVive of 23,328. This is a result of a performed subscription options program (series 2016/2017:1).

Previous page 1 2 Next page